AYVAKIT
Live / Registered — Registered (as of 12 Jul 2022)
What this means for you
Registered since 12 Jul 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88589364
- Registration number
- 6790001
- Mark type
- Design + words
- Filed
- 22 Aug 2019
- Published for opposition
- 15 Oct 2019
- Registered
- 12 Jul 2022
- Attorney of record
- Timothy H. Hiebert
Goods and services
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of cancer and mastocytosis, and in the field of pharmaceuticals for treating cancer and mastocytosis
- Class 044 — Medical, beauty and agricultural services: Providing health information to patients and their caregivers; providing health care information relating to cancer and mastocytosis, and information relating to the therapeutic properties of pharmaceuticals used for treating cancer and mastocytosis
Owner
- Blueprint Medicines Corporation, Cambridge, MA, US
- Blueprint Medicines Corporation, Cambridge, MA, US
- Blueprint Medicines Corporation, Cambridge, MA, US
Prosecution history
- 12 Jul 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Jul 2022 — REGISTERED-PRINCIPAL REGISTER
- 08 Jun 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Jun 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Jun 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Jun 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Jun 2022 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 28 Feb 2022 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 28 Feb 2022 — FINAL REFUSAL E-MAILED
- 28 Feb 2022 — SU - FINAL REFUSAL - WRITTEN
- 27 Jan 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jan 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Jan 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Jan 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Jan 2022 — NON-FINAL ACTION E-MAILED